A
Apimeds Pharmaceuticals US Inc
AMEX:APUS
Apimeds Pharmaceuticals US Inc
AMEX:APUS
Price:
1.91
USD
17.18%
Market Closed
Market Cap:
$24m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Apimeds Pharmaceuticals US Inc
AMEX:APUS
|
US |
|
Harena Resources PLC
OTC:CRMNF
|
UK |
Balance Sheet
Balance Sheet Decomposition
Apimeds Pharmaceuticals US Inc
Apimeds Pharmaceuticals US Inc
Balance Sheet Decomposition is not available for
Apimeds Pharmaceuticals US Inc
Apimeds Pharmaceuticals US Inc
Balance Sheet
Apimeds Pharmaceuticals US Inc
Apimeds Pharmaceuticals US Inc
Currency: USD
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+6 708%
|
0
-97%
|
|
| Liabilities | ||||
| Accrued Liabilities |
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
0
-46%
|
1
+251%
|
|
| Equity | ||||
| Common Stock |
0
|
0
|
0
|
|
| Retained Earnings |
2
|
3
|
4
|
|
| Additional Paid In Capital |
1
|
3
|
3
|
|
| Total Equity |
1
N/A
|
0
N/A
|
1
N/A
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+6 708%
|
0
-97%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
12
|
12
|
12
|
|
Switch to:
Switch to:
See Also
Discover More
